Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 127Carboplatin 125Pemetrexed 105Cisplatin 79Paclitaxel 58osimertinib 55Nivolumab 52Docetaxel 52durvalumab 48Specimen Handling 40Magnetic Resonance Spectroscopy 36Gemcitabine 35Radiosurgery 29atezolizumab 27Cetuximab 26130-nm albumin-bound paclitaxel 26Radiotherapy 22Ipilimumab 21Drug Therapy 21cemiplimab 20Bevacizumab 20amivantamab 18Taxes 16Ramucirumab 13tislelizumab 12alectinib 12Biopsy 12lazertinib 11Radiation 11Oxaliplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Pulmonary Surgical Procedures × 90 days × Clear all
NCT02468024 2026-04-16

STABLE-MATES

University of Texas Southwestern Medical Center

Phase 3 Recruiting
272 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡